Neptune Technologies & Bioresources Inc (NEPT)
(Delayed Data from NSDQ)
$4.24 USD
-0.03 (-0.70%)
Updated May 3, 2019 04:00 PM ET
After-Market: $4.16 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.24 USD
-0.03 (-0.70%)
Updated May 3, 2019 04:00 PM ET
After-Market: $4.16 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Neptune Wellness (NEPT) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Neptune Wellness (NEPT) delivered earnings and revenue surprises of -50% and 7.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Haemonetics (HAE) Q3 Earnings Beat Estimates
by Zacks Equity Research
Haemonetics (HAE) delivered earnings and revenue surprises of 12% and 2.58%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Boston Scientific (BSX) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Boston Scientific (BSX) delivered earnings and revenue surprises of 2.27% and 0.91%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Neptune Wellness (NEPT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Neptune Wellness (NEPT) delivered earnings and revenue surprises of 0.00% and 13.70%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Neptune Wellness (NEPT) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
by Zacks Equity Research
Neptune Wellness (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neptune Wellness (NEPT) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
by Zacks Equity Research
Neptune Wellness (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Neptune Wellness (NEPT) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Neptune Wellness (NEPT) stock based on the movements in the options market lately.
New Strong Sell Stocks for March 3rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for February 26th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Neptune Wellness (NEPT) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Neptune Wellness (NEPT) delivered earnings and revenue surprises of -150.00% and -8.09%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Neptune Wellness (NEPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Neptune Wellness (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Neptune (NEPT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Neptune (NEPT) stock based on the movements in the options market lately.
Neptune Wellness Solutions (NEPT) Reports Q1 Loss, Misses Revenue Estimates (Revised)
by Zacks Equity Research
Neptune Wellness Solutions(NEPT) delivered earnings and revenue surprises of -80.00% and -0.57%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Neptune Technologies (NEPT) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of -80.00% and -0.57%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Will Neptune Technologies (NEPT) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Neptune Tech (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Neptune Technologies (NEPT) Q4 Earnings Expected to Decline
by Zacks Equity Research
Neptune Tech (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Implied Volatility Surging for Neptune Wellness (NEPT) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Neptune Wellness (NEPT) stock based on the movements in the options market lately.
Implied Volatility Surging for Neptune Wellness (NEPT) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Neptune Wellness (NEPT) stock based on the movements in the options market lately.
Company News for Apr 3, 2020
by Zacks Equity Research
Companies In The News Are: NEPT, BMRA, LK, WBA
Is the Options Market Predicting a Spike in Neptune (NEPT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Neptune (NEPT) stock based on the movements in the options market lately.
Neptune Technologies (NEPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Neptune Tech (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Options Traders Expect Huge Moves in Neptune (NEPT) Stock
by Zacks Equity Research
Investors need to pay close attention to Neptune (NEPT) stock based on the movements in the options market lately.
Neptune Wellness Solutions (NEPT) Reports Q2 Loss, Lags Revenue Estimates (Revised)
by Zacks Equity Research
Neptune Wellness Solutions (NEPT) delivered earnings and revenue surprises of -325.00% and -23.16%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
International Flavors-Neptune Team to Co-Develop CBD Products
by Zacks Equity Research
International Flavors (IFF) focused on developing hemp-derived CBD products for customers in natural health & wellness products.
Neptune Technologies (NEPT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of -325.00% and -23.16%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?